Rifamycin sodium
Cat. No.：YN251379
| 产品名称: | Rifamycin sodium |
| CAS No.: | 14897-39-3 |
| Chemical Name: | 5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione 21-Acetate Sodium Salt; Rifamastene; Rifocin; Tuborin; Rifaximin EP Impurity C; |
| Synonyms: | Rifamycin SV sodium |
| 分子量: | 719.75 |
| 分子式: | C₃₇H₄₆NNaO₁₂ |
| SMILES: | O=C1C2=C(C([O-])=CC(NC(/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@H]3C)=O)=C4O)C4=C(O)C(C)=C2O[C@@]1(O/C=C/[C@@H]([C@H]([C@@]3([H])OC(C)=O)C)OC)C.[Na+] |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Rifamycin sodium (Rifamycin SV monosodium) 属于安沙霉素抗生素家族，从地中海曲霉或其突变体的发酵中分离出来。Rifamycin sodium 对革兰氏阳性菌和在较小程度上对革兰氏阴性菌具有广泛的抗生素活性。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
1. Sensi, P. et al.: Experientia. 1960 Sep 15
16:412. & 2. Mascherpa, P., et al.: Biochem. Pharmacol. 1966 Feb
15(2):200-4.
